TELEMS: Feasibility of Remote Patient Visits in MS
TELE MS RCT: A Randomized Controlled Trial to Evaluate Feasibility of Remote Patient Visits in People With Multiple Sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- EDSS
- Discussion of symptoms, Patient reported outcome (MSIS)
What it measured
Main measures
TMPQ
1 week after intervention
Other measures (1)
PPSM
1 week after intervention
Quality of life (reported by participants)
Who could take part
MS (type not specified) · 16 to 80
Show the full criteria
Inclusion criteria
* confirmed diagnosis of any type of MS * own a phone/smartphone/computer * informed consent
Exclusion criteria
* language barriers
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.
Papers
Loading reviews and guidelines…
History
Started
Nov 2020
Main results due
Sept 2021
Finished
Oct 2021